chr1-230920581-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024525.5(TTC13):āc.1912A>Gā(p.Lys638Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000379 in 1,583,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024525.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC13 | NM_024525.5 | c.1912A>G | p.Lys638Glu | missense_variant | 17/23 | ENST00000366661.9 | NP_078801.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC13 | ENST00000366661.9 | c.1912A>G | p.Lys638Glu | missense_variant | 17/23 | 1 | NM_024525.5 | ENSP00000355621.4 | ||
TTC13 | ENST00000366662.8 | c.1753A>G | p.Lys585Glu | missense_variant | 15/21 | 1 | ENSP00000355622.4 | |||
TTC13 | ENST00000486879.2 | c.214A>G | p.Lys72Glu | missense_variant | 4/4 | 5 | ENSP00000428447.1 | |||
TTC13 | ENST00000471302.2 | n.100A>G | non_coding_transcript_exon_variant | 2/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000349 AC: 5AN: 1431694Hom.: 0 Cov.: 28 AF XY: 0.00000562 AC XY: 4AN XY: 711954
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 09, 2024 | The c.1912A>G (p.K638E) alteration is located in exon 17 (coding exon 17) of the TTC13 gene. This alteration results from a A to G substitution at nucleotide position 1912, causing the lysine (K) at amino acid position 638 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at